ISSUE |
Myriad Genetics is a successful biopharmaceutical company whose vision is to develop medical products to improve the length and quality of life. Myriad is the world leader and pioneer in proteomics, the study of protein pathways and how they underlie the world's major human diseases. Its corporate vision is based on moving from genes to proteins to cure and ultimately to the prevention of disease. Targets cover spectrum of diseases from dementia and diabetes, to prostate cancer, rheumatoid arthritis and AIDS.

CHALLENGE |
Myriad needed a 3-dimensional display to enable investors and financial analysts to quickly evaluate and understand Myriad's fundamental technology and position in the biotech spectrum. The company's investor relations team needed to easily communicate Myriad Genetics' role as capable of stewarding shareholder value through the application of technology and business focus.

SOLUTION |
In order to perpetuate buzz about company, its vision, technology and products, Vanguard organized its presentation of Myriad around three simple concepts: vision, innovation and implementation. Vanguard designed and produced panels for Myriad's trade show booth application that invited visitors in and spurred conversation with Myriad personnel. supported their interest in the company, and ultimately helped spread word of mouth about Myriad Genetics as good company and good investment.